In short. Filler, energy devices, skin treatment, surgery and doing nothing: how each compares with a biostimulator, and the concerns that should be sent elsewhere.

Key points

  • Volume loss, tissue quality, laxity and descent are four different problems with four different answers.
  • A biostimulator addresses the first two.
  • A device addresses laxity.

A collagen biostimulator is one answer among several, and for a good number of the people who ask about it, it is not the best one. The useful question is not which treatment is strongest but which one reaches the problem you actually have. Here is how the alternatives compare on the things that decide a choice.

Filler: immediate, precise and reversible

Where the concern has an outline, filler is usually the better instrument. A defined hollow, a single fold, a chin that needs projection, a lip that needs more body: these are shaping problems. Filler is placed where it is wanted, the result is visible on the day, and it can be dissolved if you dislike it. That reversibility is worth a great deal in a face never treated, and it is the main reason to start there rather than with a course that cannot be undone.

Energy-based treatment: for laxity, not for volume

Where the concern is skin laxity rather than volume or quality, a device is the more honest answer. Energy results are incremental and normally need several sessions, they are not permanent, and post-inflammatory hyperpigmentation is a real risk, especially in darker skin. Burns, blistering and scarring occur. An energy-device course is not a facelift, and a face with genuine descent needs a surgical opinion rather than more sessions.

Match the tool to the problem, not to the fashion

Volume loss, tissue quality, laxity and descent are four different problems with four different answers. A biostimulator addresses the first two. Filler addresses shape. A device addresses laxity. An operation addresses descent. A practice that offers only one of them will tend to find that one is what you need.

Skin treatment and surgery

If the dominant complaint is surface texture, pigment or dullness, then the problem sits in the skin and should be treated there, with topical care and photoprotection. If the concern is that tissue has descended, only an operation repositions it, and a course of injections that promises otherwise is wasting both your money and your year. Both are legitimate answers to questions a biostimulator cannot reach.

Concerns that should be sent elsewhere

  • Descent of the jawline, midface or brow, which needs a surgical assessment rather than an injectable course.
  • A defined hollow or a feature whose shape you want changed, which is a filler or surgical question.
  • Pigment, texture or barrier problems, which belong to dermatology and are made worse by treating them as volume problems.

Doing nothing deserves a place on the list rather than a mention at the end. Gradual volume loss is a normal feature of a face over time, and the pressure to treat it comes at least as much from the market as from the mirror. Nothing described on this site is urgent, nothing is permanent, and the only decision that cannot be taken back is the one worth taking slowly. If your assessment ends with doing nothing for now, that is a clinical answer rather than a refusal.

Related reading

Frequently asked questions

When is filler the better answer than a biostimulator?

When the concern has an outline. A defined hollow, a single fold, a chin that needs projection or a lip that needs more body are shaping problems, and shaping is what a hyaluronic-acid filler does well. It is also reversible, which matters if you have never had treatment before.

Can an energy-based device do what a biostimulator does?

No, and the reverse is also true. A device addresses laxity by heating tissue; a biostimulator addresses tissue quality and diffuse volume. Energy results are incremental and need several sessions, they are not permanent, and post-inflammatory hyperpigmentation is a real risk, particularly in darker skin.

Is doing nothing a reasonable option?

For almost everything this site describes, yes. Gradual volume loss and a change in tissue quality are normal features of a face over time, and treating them is an aesthetic choice rather than a medical need. Nothing here is urgent, which makes waiting a genuinely low-cost option.

Risks & Limitations

  • Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
  • Irreversibility: a biostimulator cannot be dissolved. An uneven or unwanted result has to be managed over time, not switched off.
  • Infection or inflammation at the injection site.
  • Asymmetry or over-correction. Over-treatment in an area that cannot be dissolved is harder to correct than under-treatment.
  • Lumpiness or irregularity in the first weeks while the material settles, which usually resolves but occasionally does not.
  • Bruising, swelling, tenderness and occasional headache after treatment.
  • A biostimulator does not lift descended tissue and does not remove fat. The effect is gradual over months, it is not permanent, and maintenance treatment is required.

When to Seek Care

  • A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
  • Redness, warmth, swelling or pus at an injection site, or fever.
  • Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
  • Increasing pain, or pain out of proportion to the injection.
  • Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable and skin safety information
  • American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
  • U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
  • National Medical Products Administration (NMPA, China) — approved product status
  • Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.